HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $465,000 | +278.0% | 110,121 | +150.2% | 0.01% | +233.3% |
| Q2 2022 | $123,000 | -79.8% | 44,006 | -58.7% | 0.00% | -78.6% |
| Q1 2022 | $610,000 | -65.7% | 106,653 | -45.3% | 0.01% | -53.3% |
| Q4 2021 | $1,779,000 | +112.3% | 194,874 | +277.0% | 0.03% | +76.5% |
| Q1 2021 | $838,000 | -32.2% | 51,690 | -38.5% | 0.02% | -72.1% |
| Q2 2020 | $1,236,000 | -16.7% | 84,039 | +2.5% | 0.06% | +60.5% |
| Q4 2017 | $1,483,000 | +345.3% | 81,951 | +297.0% | 0.04% | +375.0% |
| Q3 2017 | $333,000 | +29.1% | 20,642 | +10.9% | 0.01% | 0.0% |
| Q2 2017 | $258,000 | +2.0% | 18,618 | +10.2% | 0.01% | 0.0% |
| Q1 2017 | $253,000 | -33.2% | 16,894 | -15.3% | 0.01% | -20.0% |
| Q1 2016 | $379,000 | -41.4% | 19,943 | -24.8% | 0.01% | -54.5% |
| Q3 2015 | $647,000 | +9.5% | 26,533 | +39.9% | 0.02% | +29.4% |
| Q2 2015 | $591,000 | +17.5% | 18,972 | -53.5% | 0.02% | -10.5% |
| Q2 2014 | $503,000 | +44.5% | 40,800 | +63.2% | 0.02% | +26.7% |
| Q1 2014 | $348,000 | – | 24,999 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |